++ Public Choice Vote until 25 February! ++ Next Call starts: 1 March 2026

++ Public Choice Vote until 25 February! ++ Next Call starts: 1 March 2026

nominated 2024

IBD Note

Takeda Pharmaceutical Company

Service Health

IBD Note is a self-management app for patients with inflammatory bowel disease (IBD), planned and developed by Takeda Pharmaceutical Company, and supervised by Dr. Kaoru Yokoyama, Department of Gastroenterology, Kitasato University School of Medicine.

Year

2024

Category

Product

Country

Japan

Design Studio / Department

Patient Service, Market Access, Public Affairs & Patient Ex, Japan Pharma Business Unit

XXX

Please first confirm that you are a human being.